Activest Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Activest Wealth Management’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-186	Closed	-$1.36K	–	1157
2024 Q4	$1.26K	Hold	186	–	–	﹤0.01%	453
2024 Q3	$1.23K	Hold	186	–	–	﹤0.01%	452
2024 Q2	$1.4K	Hold	186	–	–	﹤0.01%	423
2024 Q1	$1.85K	Hold	186	–	–	﹤0.01%	306
2023 Q4	$1.83K	Hold	186	–	–	﹤0.01%	271
2023 Q3	$1.42K	Hold	186	–	–	﹤0.01%	285
2023 Q2	$5.02K	Hold	186	–	–	﹤0.01%	222
2023 Q1	$1.2K	Hold	186	–	–	﹤0.01%	278
2022 Q4	$1.43K	Hold	186	–	–	﹤0.01%	414
2022 Q3	$2K	Hold	186	–	–	﹤0.01%	398
2022 Q2	$2K	Hold	186	–	–	﹤0.01%	338
2022 Q1	$1K	Hold	186	–	–	﹤0.01%	328
2021 Q4	$3K	Hold	186	–	–	﹤0.01%	287
2021 Q3	$4K	Buy	+186	New	+$5.27K	﹤0.01%	305

Other funds holding RXRX

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Activest Wealth Management's RXRX Position: Q1 2025 in Review

Activest Wealth Management sold out of Recursion Pharmaceuticals (RXRX) in Q1 2025, closing a stake of 186 shares — an estimated $1.36K sold.

Activest Wealth Management first reported a position in RXRX in Q3 2021 and held it in 14 quarters. The position peaked at $5.02K in Q2 2023. 336 funds tracked by Wall St. Rank hold RXRX as of Q1 2025.

Activest Wealth Management reported no remaining Recursion Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Activest Wealth Management sold 186 Recursion Pharmaceuticals shares in Q1 2025, an estimated $1.36K.
Activest Wealth Management first reported a position in Recursion Pharmaceuticals in Q3 2021 and held it in 14 quarters.
Activest Wealth Management's Recursion Pharmaceuticals position peaked at $5.02K in Q2 2023.
336 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2025.

Based on Activest Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.